Suppr超能文献

从乳糜泻诊断之时到无麸质饮食六个月后患者终末期肝病模型-钠(MELD-Na)和白蛋白水平的变化。

Change in Patient MELD-Na and Albumin Level From the Time of Celiac Disease Diagnosis to Six Months Later After Gluten-Free Diet.

作者信息

Essrani Rajesh, Berger Andrea

机构信息

Internal Medicine, Geisinger Medical Center, Danville, USA.

Internal Medicine, Lehigh Valley Health Network, Allentown, USA.

出版信息

Cureus. 2020 May 22;12(5):e8237. doi: 10.7759/cureus.8237.

Abstract

Background & aims Celiac disease (CD) is a multisystem disorder triggered by dietary gluten in genetically predisposed individuals that may affect any organ system, including the liver. We evaluated a change in patient model for end-stage liver disease (MELD)-Na and albumin level from the time of celiac disease diagnosis to six months later, after implementing a gluten-free diet. Methods A retrospective study was conducted from January 1, 2006, to June 30, 2018. CD was diagnosed based on celiac antibodies and/or histopathological data. MELD-Na and albumin were calculated at the start of the gluten-free diet and six months later. Additional variables like gender, ethnicity, serum IgA level, serum IgG level, human leukocyte antigen (HLA) type, and markers of end-stage liver disease were collected. Descriptive statistics, including means, were reported with the standard deviation for the continuous variables along with frequencies and percentages for all categorical variables. Results A total of 18 patients (55.6% male) were identified as having both cirrhosis and CD. The mean age at the time of celiac diagnosis was 53.6, and 94.4% were Caucasian. CD was diagnosed using celiac antibodies (100%) and histopathological data (44.4%). Most common celiac antibodies include anti-tissue transglutaminase antibodies (77.8%). End-stage liver disease markers like abdominal ascites (55.6%), variceal bleed (50.0%), acute or chronic kidney injury (16.7%), hepatocellular carcinoma (HCC) (11.1%), hepatic encephalopathy (HE) (50.0%), spontaneous bacterial peritonitis (SBP) (5.6%), and liver transplant (0.0%) were seen. The mean baseline MELD-Na score was 11.8, and albumin was 3.5 at the time of celiac diagnosis and mean MELD-Na was 11.8, and albumin was 3.5 six months after a gluten-free diet. Conclusion It is difficult to conclude any exact relationship between change in MELD-Na score after gluten-free diet, but an improving trend is noted in patients with higher MELD-Na score such as 17 or higher. There is no change or worsening of MELD-Na score in patients with lower MELD-Na score. There was no change in mean MELD-Na and albumin level after gluten-free diet.

摘要

背景与目的 乳糜泻(CD)是一种多系统疾病,由遗传易感性个体摄入膳食麸质引发,可能影响包括肝脏在内的任何器官系统。我们评估了在实施无麸质饮食后,从乳糜泻诊断时到六个月后患者的终末期肝病模型(MELD)-Na和白蛋白水平的变化。

方法 进行了一项回顾性研究,时间跨度为2006年1月1日至2018年6月30日。根据乳糜泻抗体和/或组织病理学数据诊断CD。在开始无麸质饮食时和六个月后计算MELD-Na和白蛋白。收集了其他变量,如性别、种族、血清IgA水平、血清IgG水平、人类白细胞抗原(HLA)类型和终末期肝病标志物。对于连续变量,报告包括均值在内的描述性统计数据以及标准差,对于所有分类变量,报告频率和百分比。

结果 共确定18例患者(55.6%为男性)同时患有肝硬化和CD。乳糜泻诊断时的平均年龄为53.6岁,94.4%为白种人。使用乳糜泻抗体(100%)和组织病理学数据(44.4%)诊断CD。最常见的乳糜泻抗体包括抗组织转谷氨酰胺酶抗体(77.8%)。观察到终末期肝病标志物,如腹水(55.6%)、静脉曲张出血(50.0%)、急性或慢性肾损伤(16.7%)、肝细胞癌(HCC)(11.1%)、肝性脑病(HE)(50.0%)、自发性细菌性腹膜炎(SBP)(5.6%)和肝移植(0.0%)。乳糜泻诊断时的平均基线MELD-Na评分为11.8,白蛋白为3.5,无麸质饮食六个月后平均MELD-Na为11.8,白蛋白为3.5。

结论 难以确定无麸质饮食后MELD-Na评分变化之间的确切关系,但在MELD-Na评分较高(如17或更高)的患者中观察到改善趋势。MELD-Na评分较低的患者中MELD-Na评分无变化或恶化。无麸质饮食后平均MELD-Na和白蛋白水平无变化。

相似文献

2
Macroamylasemia attributable to gluten-related amylase autoantibodies: a case report.
Pediatrics. 2001 Jun;107(6):E93. doi: 10.1542/peds.107.6.e93.
3
Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome.
Clin Gastroenterol Hepatol. 2007 Jul;5(7):844-50; quiz 769. doi: 10.1016/j.cgh.2007.03.021. Epub 2007 Jun 5.
5
Celiac disease or non-celiac gluten sensitivity? An approach to clinical differential diagnosis.
Am J Gastroenterol. 2014 May;109(5):741-6; quiz 747. doi: 10.1038/ajg.2014.41. Epub 2014 Mar 11.
9
A Caucasian American patient with celiac disease diagnosed in Japan and successfully treated with a gluten-free diet.
Clin J Gastroenterol. 2018 Feb;11(1):23-28. doi: 10.1007/s12328-017-0794-4. Epub 2017 Nov 1.

引用本文的文献

1
Unraveling the Serum Protein Landscape in Celiac Disease: Current Evidence and Future Directions.
Immun Inflamm Dis. 2025 May;13(5):e70169. doi: 10.1002/iid3.70169.
2
Liver function changes following the introduction of a gluten-free diet in patients with celiac disease.
Clin Exp Hepatol. 2021 Dec;7(4):415-421. doi: 10.5114/ceh.2021.111003. Epub 2021 Dec 23.

本文引用的文献

1
Investigation into celiac disease in Indian patients with portal hypertension.
Indian J Gastroenterol. 2014 Nov;33(6):517-23. doi: 10.1007/s12664-014-0501-z. Epub 2014 Sep 18.
2
Update on the management of cirrhosis - focus on cost-effective preventative strategies.
Clinicoecon Outcomes Res. 2013 Apr 12;5:143-52. doi: 10.2147/CEOR.S30675. Print 2013.
3
ACG clinical guidelines: diagnosis and management of celiac disease.
Am J Gastroenterol. 2013 May;108(5):656-76; quiz 677. doi: 10.1038/ajg.2013.79. Epub 2013 Apr 23.
5
Gluten-sensitive hypertransaminasemia in celiac disease: an infrequent and often subclinical finding.
Am J Gastroenterol. 2011 Sep;106(9):1689-96. doi: 10.1038/ajg.2011.134. Epub 2011 Apr 19.
7
Cognitive impairment and celiac disease.
Arch Neurol. 2006 Oct;63(10):1440-6. doi: 10.1001/archneur.63.10.1440.
8
Is coeliac disease a potentially treatable cause of liver failure?
Eur J Gastroenterol Hepatol. 2005 Oct;17(10):1015-7. doi: 10.1097/00042737-200510000-00002.
9
Skin manifestations of celiac disease.
Gastroenterology. 2005 Apr;128(4 Suppl 1):S87-91. doi: 10.1053/j.gastro.2005.02.026.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验